WellStreet Urgent Care, bioMérieux celebrate 200,000 patients served through BIOFIRE® SPOTFIRE® tests in urgent care clinics across Georgia, Ohio and South Ca…

WellStreet Urgent Care, an expert in developing and scaling urgent care networks with health system partners, and bioMérieux, ...
MarketWatch

Altesa BioSciences and bioMérieux Announce Collaboration for Altesa's Upcoming Phase 2B COPD Clinical Trial

The MarketWatch News Department was not involved in the creation of this content. Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE(R) SPOTFIRE(R) point-of-care ...
Medindia

bioM rieux Receives Health Canada Approval for the BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel

MONTREAL, Feb. 25, 2025 /CNW/ - bioM rieux, a world leader in the field of in vitro diagnostics, has achieved a significant milestone with the Health Canada approval of the BIOFIRE SPOTFIRE ...
Yahoo Finance

Should Altesa BioSciences’ Use of SPOTFIRE Shift bioMérieux’s (ENXTPA:BIM) Diagnostic Market Position?

On September 9, 2025, Altesa BioSciences announced a partnership with bioMérieux to use the BIOFIRE SPOTFIRE respiratory diagnostic platform as the primary point-of-care tool in its upcoming Phase 2B ...
Yahoo Finance

Altesa BioSciences and bioMérieux Announce Collaboration for Altesa's Upcoming Phase 2B COPD Clinical Trial

Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE® SPOTFIRE® point-of-care diagnostics platform at U.S. sites ATLANTA and SALT LAKE CITY, Sept. 9, 2025 /PRNewswire/ -- ...
Medindia

bioMérieux Receives Health Canada Approval for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel

MONTREAL, Feb. 25, 2025 /CNW/ - bioMérieux, a world leader in the field of in vitro diagnostics, has achieved a significant milestone with the Health Canada approval of the BIOFIRE® SPOTFIRE® ...